News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mark Lythgoe: Great to be editors pick in The Lancet Oncology this month
Mark Lythgoe/X
Apr 3, 2025, 09:48

Mark Lythgoe: Great to be editors pick in The Lancet Oncology this month

Mark Lythgoe, Clinical Research Fellow in Medical Oncology at Imperial College London, shared a post on X:

“Great to be editors pick in The Lancet Oncology this month for our comment….highlighting Sexual health and reproductive toxicity from cancer therapies.”

Mark Lythgoe

cancer Mark Lythgoe OncoDaily Oncology The Lancet Oncology
Special Coverage
Blog
May 1, 2025, 18:12
Alastair Lamb highlights BJUI session on AI and Medicolegal topics at AUA25
Blog
May 1, 2025, 18:05
Misty Dawn Shields: An amazing night at the "Evening of Promise" gala hosted by American Lung Association
Blog
May 1, 2025, 18:04
Karuna Ganesh reveals E. coli’s role in early-onset colorectal cancer Initiation at AACR25
Drugs
May 1, 2025, 17:54
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Insight
May 1, 2025, 17:49
Miguel Bronchud shared insights on the tumor microenvironment in cancer progression
Opinion
May 1, 2025, 17:39
Daniel Flora: Letter to my new cancer patients - What I want you to know as we begin this journey
Insight
May 1, 2025, 17:30
Gustavo Viani: Supercharged Spinal Metastases SBRT-SIB Boost Scores High Local Control 
Blog
May 1, 2025, 17:29
Muhammad Shaalan Beg shared methods to reimagine patient-centric clinical trials at AACR25 - Moffitt Cancer Center
Blog
May 1, 2025, 17:15
Shaban Juma Shares Vital Insights on Lung Cancer and Its Primary Risk Factors - Cancer Fight Tanzania
Drugs
May 1, 2025, 17:14
Ana Velázquez Mañana highlights NEJM study by John Heymach on Zongertinib’s efficacy in HER2-Mutant NSCLC at AACR25
Blog
May 1, 2025, 17:09
Aynur Aktas: Our Abstract Has Been Selected for Oral Presentation at MASCC 2025
Insight
May 1, 2025, 17:01
Ken Cardona leads EA7211/STRASS 2 clinical trial: A randomized study in retroperitoneal sarcoma - ECOG-ACRIN Cancer Research Group